Explore
Validate
LearnHPA031613
antibody from Atlas Antibodies
Targeting: CCR4
CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA031613 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA031613, RRID:AB_10601096
- Product name
- Anti-CCR4
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human CCR4, Gene description: chemokine (C-C motif) receptor 4, Alternative Gene Names: CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5, Validated applications: IHC, Uniprot ID: P51679, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells.
Anti-HMGCR Antibody-Positive Myopathy Shows Bcl-2-Positive Inflammation and Lymphocytic Accumulations
Han B, Lim S, Yim J, Song Y, Koh J, Kim S, Lee C, Kim Y, Jeon Y
Journal of Pathology and Translational Medicine 2024;58(2):59-71
Journal of Pathology and Translational Medicine 2024;58(2):59-71
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma
Watanabe K, Gomez A, Kuramitsu S, Siurala M, Da T, Agarwal S, Song D, Scholler J, Rotolo A, Posey A, Rook A, Haun P, Ruella M, Young R, June C
Blood Advances 2023;7(14):3416-3430
Blood Advances 2023;7(14):3416-3430
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells.
Kolben T, Mannewitz M, Perleberg C, Schnell K, Anz D, Hahn L, Meister S, Schmoeckel E, Burges A, Czogalla B, Hester A, Mahner S, Kessler M, Jeschke U, Corradini S, Trillsch F, Beyer S
Cellular oncology (Dordrecht, Netherlands) 2022 Dec;45(6):1171-1185
Cellular oncology (Dordrecht, Netherlands) 2022 Dec;45(6):1171-1185
Anti-HMGCR Antibody-Positive Myopathy Shows Bcl-2-Positive Inflammation and Lymphocytic Accumulations
Kurashige T, Murao T, Mine N, Sugiura T, Inazuka Y, Kuraoka K, Takahashi T, Maruyama H, Torii T
Journal of Neuropathology & Experimental Neurology 2020;79(4):448-457
Journal of Neuropathology & Experimental Neurology 2020;79(4):448-457
No comments: Submit comment
No validations: Submit validation data